Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Non-Current Assets (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Non-Current Assets for 16 consecutive years, with $50.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 4.13% to $50.0 million in Q4 2025 year-over-year; TTM through Nov 2025 was $204.7 million, a 2.08% decrease, with the full-year FY2025 number at $50.0 million, down 4.13% from a year prior.
  • Non-Current Assets was $50.0 million for Q4 2025 at Cryo Cell International, down from $51.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $86.6 million in Q1 2021 to a low of -$14.5 million in Q2 2021.
  • A 5-year average of $50.3 million and a median of $52.2 million in 2024 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: crashed 152.73% in 2021, then soared 410.26% in 2022.
  • Cryo Cell International's Non-Current Assets stood at $44.9 million in 2021, then grew by 23.17% to $55.3 million in 2022, then fell by 0.1% to $55.2 million in 2023, then fell by 5.62% to $52.1 million in 2024, then decreased by 4.13% to $50.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Non-Current Assets are $50.0 million (Q4 2025), $51.5 million (Q3 2025), and $51.4 million (Q2 2025).